Clinical Trials Directory

Trials / Conditions / Recurrent Adult Brain Neoplasm

Recurrent Adult Brain Neoplasm

18 registered clinical trials studyying Recurrent Adult Brain Neoplasm.

StatusTrialSponsorPhase
CompletedLapatinib Ditosylate Before Surgery in Treating Patients With Recurrent High-Grade Glioma
NCT02101905
National Cancer Institute (NCI)Phase 1
WithdrawnNovoTTF-100A With Bevacizumab and Carmustine in Treating Patients With Glioblastoma Multiforme in First Relaps
NCT02348255
University of California, DavisPhase 2
CompletedSorafenib, Valproic Acid, and Sildenafil in Treating Patients With Recurrent High-Grade Glioma
NCT01817751
Virginia Commonwealth UniversityPhase 2
CompletedBevacizumab With or Without Anti-Endoglin Monoclonal Antibody TRC105 in Treating Patients With Recurrent Gliob
NCT01648348
National Cancer Institute (NCI)Phase 1 / Phase 2
TerminatedHigh-Dose Vorinostat and Fractionated Stereotactic Body Radiation Therapy in Treating Patients With Recurrent
NCT01378481
National Cancer Institute (NCI)Phase 1
CompletedVaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors
NCT01522820
Roswell Park Cancer InstitutePhase 1
TerminatedGadobutrol Versus Gadopentetate Dimeglumine or Gadobenate Dimeglumine Before DCE-MRI in Diagnosing Patients Wi
NCT02967380
University of Southern CaliforniaN/A
CompletedGamma-Secretase Inhibitor RO4929097 and Cediranib Maleate in Treating Patients With Advanced Solid Tumors
NCT01131234
National Cancer Institute (NCI)Phase 1
CompletedCediranib Maleate and Cilengitide in Treating Patients With Progressive or Recurrent Glioblastoma
NCT00979862
National Cancer Institute (NCI)Phase 1
CompletedTemsirolimus and Perifosine in Treating Patients With Recurrent or Progressive Malignant Glioma
NCT01051557
National Cancer Institute (NCI)Phase 1 / Phase 2
TerminatedCilengitide and Sunitinib Malate in Treating Patients With Advanced Solid Tumors or Glioblastoma Multiforme
NCT01122888
National Cancer Institute (NCI)Phase 1
CompletedEverolimus in Treating Patients With Recurrent Low-Grade Glioma
NCT00823459
Susan ChangPhase 2
CompletedBendamustine Hydrochloride in Treating Patients With Recurrent or Progressive Anaplastic Glioma
NCT00823797
University of WashingtonPhase 2
CompletedBevacizumab and Irinotecan or Temozolomide in Treating Patients With Recurrent or Refractory Glioblastoma Mult
NCT00433381
National Cancer Institute (NCI)Phase 2
CompletedDasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
NCT00423735
National Cancer Institute (NCI)Phase 2
CompletedSorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
NCT00329719
National Cancer Institute (NCI)Phase 1 / Phase 2
Active Not RecruitingVorinostat and Temozolomide in Treating Patients With Malignant Gliomas
NCT00268385
National Cancer Institute (NCI)Phase 1
CompletedImatinib Mesylate in Treating Patients With Recurrent Brain Tumor
NCT00049127
Alliance for Clinical Trials in OncologyPhase 1 / Phase 2